ONCOMED PHARMACEUTICALS INC - COM (OMED) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2019

Type / Class
Equity / COM
Symbol
OMED
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2019 Q2 0 $0 -$16,936,998 0
2019 Q1 16,287,869 $16,937,000 -$584,055 $1.04 35
2018 Q4 17,471,639 $13,056,000 -$3,982,355 $0.75 36
2018 Q3 18,972,210 $40,226,000 -$803,702 $2.12 50
2018 Q2 19,200,851 $44,353,514 +$95,454 $2.31 60
2018 Q1 19,183,449 $61,003,000 -$5,144,844 $3.18 59
2017 Q4 20,471,436 $83,927,000 +$2,170,364 $4.10 66
2017 Q3 19,485,925 $88,073,000 +$5,615,978 $4.52 57
2017 Q2 19,629,650 $65,304,000 -$6,631,540 $3.33 65
2017 Q1 16,940,135 $156,017,901 +$25,316,632 $9.21 85
2016 Q4 15,912,718 $122,692,847 -$2,239,468 $7.71 85
2016 Q3 15,948,384 $180,780,886 +$50,990,734 $11.43 84
2016 Q2 11,472,168 $141,218,086 +$10,110,140 $12.31 82
2016 Q1 10,715,429 $108,379,000 -$5,400,874 $10.11 81
2015 Q4 10,967,693 $247,200,619 +$12,250,973 $22.54 82
2015 Q3 10,566,097 $175,282,214 +$81,944 $16.59 85
2015 Q2 10,520,503 $236,692,478 +$12,005,439 $22.50 81
2015 Q1 9,961,353 $256,614,967 +$2,840,873 $25.78 77
2014 Q4 8,227,714 $179,026,384 +$11,249,735 $21.76 65
2014 Q3 7,541,327 $142,749,814 +$15,361,263 $18.93 60
2014 Q2 6,652,701 $154,994,095 +$13,360,947 $23.30 62
2014 Q1 5,928,985 $199,504,408 +$25,365,894 $33.65 53